Lynda Bourebaba

874 total citations
35 papers, 581 citations indexed

About

Lynda Bourebaba is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Lynda Bourebaba has authored 35 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Epidemiology. Recurrent topics in Lynda Bourebaba's work include Adipose Tissue and Metabolism (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hormonal and reproductive studies (4 papers). Lynda Bourebaba is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hormonal and reproductive studies (4 papers). Lynda Bourebaba collaborates with scholars based in Poland, United States and Algeria. Lynda Bourebaba's co-authors include Krzysztof Marycz, Malwina Mularczyk, Michael Röcken, Katarzyna Kornicka‐Garbowska, Fatiha Bedjou, Izabela Michalak, Agnieszka Śmieszek, Jacek Łyczko, Andrzej Fal and Michalina Alicka and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Stem Cells.

In The Last Decade

Lynda Bourebaba

33 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynda Bourebaba Poland	16	227	110	98	84	72	35	581
Sudipta Chakrabarti India	14	185 0.8×	73 0.7×	83 0.8×	64 0.8×	117 1.6×	80	726
Н. П. Бгатова Russia	12	150 0.7×	90 0.8×	39 0.4×	84 1.0×	33 0.5×	69	483
Haruki Usuda Japan	15	288 1.3×	142 1.3×	144 1.5×	43 0.5×	38 0.5×	33	728
Ji‐Houn Kang South Korea	16	213 0.9×	75 0.7×	54 0.6×	68 0.8×	32 0.4×	75	770
Zohreh Hajheydari Iran	17	177 0.8×	161 1.5×	83 0.8×	47 0.6×	35 0.5×	48	953
Andres Arend Estonia	13	176 0.8×	75 0.7×	83 0.8×	39 0.5×	56 0.8×	56	593
Amira Hassouna Egypt	16	189 0.8×	43 0.4×	58 0.6×	90 1.1×	36 0.5×	29	638
Tamara Saksida Serbia	18	263 1.2×	48 0.4×	57 0.6×	96 1.1×	52 0.7×	50	831
Raul Hernandes Bortolin Brazil	15	217 1.0×	44 0.4×	49 0.5×	73 0.9×	33 0.5×	46	599

Countries citing papers authored by Lynda Bourebaba

Since Specialization

Citations

This map shows the geographic impact of Lynda Bourebaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Bourebaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Bourebaba more than expected).

Fields of papers citing papers by Lynda Bourebaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynda Bourebaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Bourebaba. The network helps show where Lynda Bourebaba may publish in the future.

Co-authorship network of co-authors of Lynda Bourebaba

This figure shows the co-authorship network connecting the top 25 collaborators of Lynda Bourebaba. A scholar is included among the top collaborators of Lynda Bourebaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynda Bourebaba. Lynda Bourebaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soltero‐Rivera, Maria, Boaz Arzi, Lynda Bourebaba, & Krzysztof Marycz. (2025). Impact of pro-inflammatory cytokine preconditioning on metabolism and extracellular vesicles in feline mesenchymal stromal cells: a preliminary study. Stem Cells. 43(7). 2 indexed citations

Bourebaba, Lynda, et al.. (2023). The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity. International Journal of Inflammation. 2023. 1–22. 5 indexed citations

Bourebaba, Lynda, et al.. (2023). Sex Hormone-Binding Globulin (SHBG) Maintains Proper Equine Adipose-Derived Stromal Cells (ASCs)’ Metabolic Functions and Negatively Regulates their Basal Adipogenic Potential. Stem Cell Reviews and Reports. 19(7). 2251–2273. 2 indexed citations

Marycz, Krzysztof, et al.. (2023). In Vitro Generated Equine Hepatic-Like Progenitor Cells as a Novel Potent Cell Pool for Equine Metabolic Syndrome (EMS) Treatment. Stem Cell Reviews and Reports. 19(4). 1124–1134. 2 indexed citations

Bourebaba, Lynda, et al.. (2023). The PTP1B inhibitor MSI-1436 ameliorates liver insulin sensitivity by modulating autophagy, ER stress and systemic inflammation in Equine metabolic syndrome affected horses. Frontiers in Endocrinology. 14. 1149610–1149610. 6 indexed citations

Bourebaba, Lynda, et al.. (2023). Equine Hoof Progenitor Cells Display Increased Mitochondrial Metabolism and Adaptive Potential to a Highly Pro-Inflammatory Microenvironment. International Journal of Molecular Sciences. 24(14). 11446–11446.

Bourebaba, Lynda, et al.. (2023). Sex hormone-binding globulin improves lipid metabolism and reduces inflammation in subcutaneous adipose tissue of metabolic syndrome-affected horses. Frontiers in Molecular Biosciences. 10. 1214961–1214961. 2 indexed citations

Bourebaba, Lynda, Katarzyna Kornicka‐Garbowska, Larry D. Galuppo, & Krzysztof Marycz. (2022). Artificial Mitochondrial Transfer (AMT) for the Management of Age-related Musculoskeletal Degenerative Disorders: An Emerging Avenue for Bone and Cartilage Metabolism Regulation. Stem Cell Reviews and Reports. 18(6). 2195–2201. 4 indexed citations

Mularczyk, Malwina, et al.. (2022). Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis. Biomolecules. 12(8). 1039–1039. 12 indexed citations

10.

Marycz, Krzysztof, et al.. (2022). Calystegines Improve the Metabolic Activity of Human Adipose Derived Stromal Stem Cells (ASCs) under Hyperglycaemic Condition through the Reduction of Oxidative/ER Stress, Inflammation, and the Promotion of the AKT/PI3K/mTOR Pathway. Biomolecules. 12(3). 460–460. 6 indexed citations

11.

Marycz, Krzysztof, Katarzyna Kornicka‐Garbowska, Larry D. Galuppo, & Lynda Bourebaba. (2021). The Hepatic Stellate Cells (HSTCs) and Adipose-derived Mesenchymal Stem Cells (ASCs) Axis as a Potential Major Driver of Metabolic Syndrome – Novel Concept and Therapeutic Implications. Stem Cell Reviews and Reports. 18(4). 1417–1422. 1 indexed citations

12.

Kornicka‐Garbowska, Katarzyna, et al.. (2021). Hyoscyamus albus nortropane alkaloids reduce hyperglycemia and hyperinsulinemia induced in HepG2 cells through the regulation of SIRT1/NF-kB/JNK pathway. Cell Communication and Signaling. 19(1). 61–61. 8 indexed citations

13.

Bourebaba, Lynda, Jacek Łyczko, Michalina Alicka, et al.. (2020). Inhibition of Protein-Tyrosine Phosphatase PTP1B and LMPTP Promotes Palmitate/Oleate-Challenged HepG2 Cell Survival by Reducing Lipoapoptosis, Improving Mitochondrial Dynamics and Mitigating Oxidative and Endoplasmic Reticulum Stress. Journal of Clinical Medicine. 9(5). 1294–1294. 28 indexed citations

14.

Bourebaba, Lynda, et al.. (2020). Cladophora glomerata enriched by biosorption with Mn(II) ions alleviates lipopolysaccharide‐induced osteomyelitis‐like model in MC3T3‐E1, and 4B12 osteoclastogenesis. Journal of Cellular and Molecular Medicine. 24(13). 7282–7300. 14 indexed citations

15.

Mularczyk, Malwina, et al.. (2020). Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome. Biomedicine & Pharmacotherapy. 134. 111113–111113. 23 indexed citations

16.

Bourebaba, Lynda, et al.. (2019). Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders. Stem Cell Reviews and Reports. 16(2). 301–322. 27 indexed citations

17.

Bourebaba, Lynda, et al.. (2019). Cladophora glomerata methanolic extract promotes chondrogenic gene expression and cartilage phenotype differentiation in equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome. Stem Cell Research & Therapy. 10(1). 392–392. 16 indexed citations

18.

Bourebaba, Lynda, Michael Röcken, & Krzysztof Marycz. (2019). Osteochondritis dissecans (OCD) in Horses – Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy. Stem Cell Reviews and Reports. 15(3). 374–390. 19 indexed citations

19.

Bourebaba, Lynda, Izabela Michalak, Michael Röcken, & Krzysztof Marycz. (2018). Cladophora glomerata methanolic extract decreases oxidative stress and improves viability and mitochondrial potential in equine adipose derived mesenchymal stem cells (ASCs). Biomedicine & Pharmacotherapy. 111(2). 6–18. 26 indexed citations

20.

Bourebaba, Lynda, et al.. (2016). Evaluation of antidiabetic effect of total calystegines extracted from Hyoscyamus albus. Biomedicine & Pharmacotherapy. 82. 337–344. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact